Case number 1:18-cv-00275
Pharmacyclics LLC et al v. Zydus Worldwide DMCC et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 11, 2021 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. [561] in Lead Civil Action No. 18-192. (fms) Modified on 5/11/2021 (fms). |
| Nov 26, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Whereas the Court directed the parties during the October 17, 2018 hearing to file a proposed scheduling order using the Court's form order and whereas the parties have not done so, it is hereby ORDERED that the parties shall file by no later than November 29, 2018 a proposed scheduling order using the Court's form order (revised as of November 14, 2018) that incorporates the dates and discovery limitations currently in effect. It is further ORDERED that for all purposes other than trial, these cases are to be treated as consolidated and all filings are to be made in Lead Case No. 18-192-CFC. Signed by Judge Colm F. Connolly on 11/26/2018. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(nmf) |
| Nov 26, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-00192-CFC. ALL FUTURE FILINGS are to be made in Lead Case No. 18-cv-192-CFC. (nmf) |
| Nov 2, 2018 | 79 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Oct 30, 2018 | 78 | Protective Order (30) Docket Text: PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 10/29/2018. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(fms) |
| Oct 29, 2018 | 77 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants Fresenius Kabi USA LLC, Fresenius Kabi Oncology Limited, Zydus Worldwide DMCC, Cadila Healthcare Limited, Teva Pharmaceuticals USA, Inc., Sandoz Inc., and Lek Pharmaceuticals d.d.'s First Set of Requests for Production of Documents and Things (Nos. 1-99) filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Tigan, Jeremy) |
| Oct 26, 2018 | 76 | Proposed Order (30) Docket Text: PROPOSED ORDER // Protective Order by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Tigan, Jeremy) |
| Oct 22, 2018 | 75 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses to Defendants' First Set of Joint Interrogatories (Nos. 1-4) filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Tigan, Jeremy) |
| Oct 18, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER, Having reviewed the parties' submissions and heard oral argument relating to two disputes over the otherwise agreed-upon protective order (PO) in Civil Actions 18-192-CFC, 18-237-CFC, 18-247-CFC, and 18-275-CFC, IT IS HEREBY ORDERED that Defendants proposal with respect to paragraphs 19 and 20 of the contemplated PO, which would prohibit Plaintiffs from disclosing confidential information (CI) produced to Plaintiffs in discovery by any one Defendant to the outside counsel and experts of any other Defendant without first obtaining the producing Defendants consent, is REJECTED for the reasons stated by the Court and made clear by the Courts questioning of the parties at oral argument on October 17, 2018. The Court further notes that its decision was informed by the following: (1) this action is one of four actions that have been effectively consolidated for pre-trial purposes with a single schedule (including a consolidated Markman hearing) and common discovery; (2) Plaintiffs have proposed a reasonable alternative to Defendants' proposal that would limit the cross-disclosure of CI to Defendants' outside counsel and experts; (3) Defendants agree that their outside counsel are not competitive decision makers and are subject to an agreed-upon prosecution bar in the contemplated PO; (4) the deadline for the parties to identify their respective experts affords each Defendant sufficient time to seek Court intervention in the event a Defendant believes (i) an identified expert is a competitive decision maker or should be subject to the PO's prosecution bar, and/or (ii) good cause exists to prohibit the expert in question from having access to a Defendants CI; (5) Defendants' proposal would place an undue, unfair, and unnecessary burden on Plaintiffs; (6) Defendants' proposal would lead to significant disruptions in discovery, depositions, and court proceedings and would impose an undue burden on the Court; and (7) Defendants have not demonstrated that restrictions beyond Plaintiffs' proposed alternative are necessary to avoid the risk that a co-Defendant would use a producing Defendants' CI's to the competitive disadvantage of the producing Defendant. Ordered by Judge Colm F. Connolly on 10/18/2018. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(nmf) |
| Oct 17, 2018 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Discovery Conference held on 10/17/2018. (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(nmf) |
| Oct 16, 2018 | 74 | Letter (4) Docket Text: Letter to The Honorable Colm F. Connolly from Jeremy A. Tigan regarding the proposed Protective Order - re (45 in 1:18-cv-00192-CFC, 39 in 1:18-cv-00247-CFC, 57 in 1:18-cv-00237-CFC, 73 in 1:18-cv-00275-CFC) Letter. (Attachments: # (1) Exhibits A-D)(Tigan, Jeremy) |
| Oct 16, 2018 | 74 | Exhibits A-D (85) |
| Oct 15, 2018 | 73 | Letter (7) Docket Text: Letter to The Honorable Colm F. Connolly from Dominick T. Gattuso regarding Opening Discovery Dispute Letter. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Gattuso, Dominick) |
| Oct 15, 2018 | 73 | Exhibit A (37) |
| Oct 15, 2018 | 73 | Exhibit B (4) |
| Oct 12, 2018 | 72 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions filed by Janssen Biotech, Inc., Pharmacyclics LLC.(Tigan, Jeremy) |
| Oct 9, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (71 in 1:18-cv-00275-CFC, 44 in 1:18-cv-00192-CFC, 55 in 1:18-cv-00237-CFC) STIPULATION TO EXTEND TIME to EXTEND the deadline for Defendants' Initial Invalidity Contentions to 11/2/2018 filed by Fresenius Kabi USA, LLC, (38 in 1:18-cv-00247-CFC) STIPULATION TO EXTEND TIME to Extend Deadline for Initial Invalidity Contentions to November 2, 2018 filed by Cipla Limited, Cipla USA Inc.. Signed by Judge Colm F. Connolly on 10/9/2018. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(fms) |
| Oct 5, 2018 | 71 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME to EXTEND the deadline for Defendants' Initial Invalidity Contentions to 11/2/2018 - filed by Fresenius Kabi USA, LLC. (Farnan, Brian) |
| Oct 3, 2018 | N/A | Set/Reset Hearings (0) Docket Text: Set Hearings: A Discovery Conference is set for 10/17/2018 at 11:00 AM per request of counsel in Courtroom 4B before Judge Colm F. Connolly. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(nmf) |
| Oct 1, 2018 | 70 | Order (4) Docket Text: ORDER: IT IS ORDERED that on or before October 22, 2018, each party or each party group shall email to Chief Magistrate Judge Thynge, with a copy to her Judicial Administrator, Cathleen Kennedy, information requested regarding ADR. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 10/1/18. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC(cak) |
| Sep 20, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Hershy Stern,Jay R. Deshmukh for Cadila Healthcare Limited, Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| Sep 20, 2018 | N/A | Case Reassigned to CFC (0) Docket Text: Case reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:18-cv-00192-CFC, 1:18-cv-00237-CFC, 1:18-cv-00247-CFC, 1:18-cv-00275-CFC (rjb) |
| Sep 19, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [69] MOTION for Pro Hac Vice Appearance of Attorney Jay R. Deshmukh and Hershy Stern of Kasowitz Benson Torres LLP filed by Zydus Worldwide DMCC, Cadila Healthcare Limited. Ordered by Judge Gregory M. Sleet on 9/19/2018. (mdb) |
| Sep 18, 2018 | 67 | Notice (Other) (2) Docket Text: NOTICE of Joinder in Defendants Fresenius Kabi's, Zydus's, Teva's, Sun's, and Cipla's First Set of Joint Interrogatories to Plaintiffs (Nos. 1-4) served on September 7, 2018 in C.A. Nos. 18-192 (GMS), 18-275 (GMS), 18-237 (GMS) and 18-247(GMS); and (ii) Defendants Fresenius Kabi's, Zydus's and Teva's First Set of Requests for Production of Documents and Things to Plaintiffs (1-99) by Lek Pharmaceuticals d.d., Sandoz Inc. re [64] Notice of Service, [65] Notice of Service (Gattuso, Dominick) |
| Sep 18, 2018 | 68 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Richard J. Berman, Janine A. Carlan, Bradford C. Frese, Taniel Anderson and Gary A. Coad of Arent Fox LLP as co-counsel. Reason for request: no longer working on case. (Palapura, Bindu) |
| Sep 18, 2018 | 69 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jay R. Deshmukh and Hershy Stern of Kasowitz Benson Torres LLP - filed by Cadila Healthcare Limited, Zydus Worldwide DMCC. (Palapura, Bindu) |
| Sep 13, 2018 | 66 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Jay R. Deshmukh as co-counsel. Reason for request: no longer with the firm of Arent Fox LLP. (Palapura, Bindu) |
| Sep 7, 2018 | 64 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Fresenius Kabi's, Zydus's, Sun's, Cipla's and Teva's First Set of Joint Interrogatories to Plaintiffs (Nos. 1-4) filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Sep 7, 2018 | 65 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Fresenius Kabi's, Zydus's, and Teva's First Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 1-99) filed by Fresenius Kabi Oncology Limited, Fresenius Kabi USA, LLC.(Farnan, Brian) |
| Sep 5, 2018 | 60 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.'s Responses to Plaintiffs' First Set of Requests (Nos. 1-11) to Teva Pharmaceuticals USA, Inc. for the Production of Documents and Things filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Sep 5, 2018 | 61 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sandoz Inc. and Lek Pharmaceuticals d.d.'s Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things [CONFIDENTIAL] filed by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick) |
| Sep 5, 2018 | 62 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Defendants' Responses and Objections to Plaintiffs' First Set of Requests (Nos. 1-11) for the Production of Documents and Things (Confidential) filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(Moore, David) |
| Sep 5, 2018 | 63 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of 1) Plaintiffs' Initial Infringement Contentions (as to Defendants Zydus Worldwide DMCC and Cadila Healthcare Limited) and 2) Plaintiffs' Initial Infringement Contentions (as to Defendants Sandoz Inc. and Lek Pharmaceuticals d.d.) filed by Janssen Biotech, Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Aug 29, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (33 in 1:18-cv-00247-GMS, 59 in 1:18-cv-00275-GMS, 37 in 1:18-cv-00192-GMS, 48 in 1:18-cv-00237-GMS) STIPULATION TO EXTEND TIME for the parties to submit their Protective Order to September 7, 2018 filed by Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 8/29/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Aug 27, 2018 | 59 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit their Protective Order to September 7, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC. (Blumenfeld, Jack) |
| Aug 22, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (31 in 1:18-cv-00247-GMS, 57 in 1:18-cv-00275-GMS, 46 in 1:18-cv-00237-GMS, 35 in 1:18-cv-00192-GMS) STIPULATION TO EXTEND TIME for the parties to submit their protective order to August 20, 2018 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC, (58 in 1:18-cv-00275-GMS, 32 in 1:18-cv-00247-GMS, 36 in 1:18-cv-00192-GMS, 47 in 1:18-cv-00237-GMS) STIPULATION TO EXTEND TIME for the parties to submit their Protective Order to August 27, 2018 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 8/22/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Aug 20, 2018 | 58 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit their Protective Order to August 27, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Blumenfeld, Jack) |
| Aug 13, 2018 | 57 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit their protective order to August 20, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Blumenfeld, Jack) |
| Aug 6, 2018 | 56 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests (Nos. 1-11) to Teva Pharmaceuticals USA, Inc. for the Production of Documents and Things; (2) Plaintiffs' First Set of Requests (Nos. 1-11) to Zydus Worldwide DMCC and Cadila Healthcare Limited for the Production of Documents and Things; and (3) Plaintiffs' First Set of Requests (Nos. 1-11) to Sandoz Inc. and Lek Pharmaceuticals D.D. for the Production of Documents and Things filed by Janssen Biotech, Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Jul 31, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (55 in 1:18-cv-00275-GMS, 44 in 1:18-cv-00237-GMS, 29 in 1:18-cv-00247-GMS, 33 in 1:18-cv-00192-GMS) STIPULATION TO EXTEND TIME for the parties to submit the Protective Order to August 13, 2018 filed by Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 7/31/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Jul 27, 2018 | 55 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit the Protective Order to August 13, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC. (Noreika, Maryellen) |
| Jul 20, 2018 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(fms) |
| Jul 18, 2018 | 53 | Notice (Other) (1) Docket Text: NOTICE of Withdrawal of Attorney Carolina Veltri by Lek Pharmaceuticals d.d., Sandoz Inc. (Gattuso, Dominick) |
| Jul 18, 2018 | 54 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Sandoz Inc.'s Production of Core Technical Documents Bearing Bates Numbers SANDOZIBRUT00000001 to SANDOZIBRUT00026328 [HIGHLY CONFIDENTIAL, OUTSIDE COUNSEL EYES ONLY] filed by Sandoz Inc..(Gattuso, Dominick) |
| Jul 9, 2018 | 52 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sandoz Inc.'s and Lek Pharmaceutical d.d.'s (1) Paragraph 3 Initial Disclosures, and (2) Rule 26(a)(1) Initial Disclosures filed by Lek Pharmaceuticals d.d., Sandoz Inc..(Gattuso, Dominick) |
| Jul 5, 2018 | 51 | Answer to Counterclaim (30) Docket Text: ANSWER to [27] Answer to Complaint, Counterclaim by Janssen Biotech, Inc., Pharmacyclics LLC.(Blumenfeld, Jack) |
| Jul 2, 2018 | 49 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, with Jury Demand by Lek Pharmaceuticals d.d..(Gattuso, Dominick) |
| Jul 2, 2018 | 50 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Lek Pharmaceuticals d.d. filed by Lek Pharmaceuticals d.d.. (Gattuso, Dominick) |
| Jun 29, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (40 in 1:18-cv-00237-GMS, 28 in 1:18-cv-00247-GMS, 48 in 1:18-cv-00275-GMS, 32 in 1:18-cv-00192-GMS) Proposed Scheduling Order: Cases referred to the Magistrate Judge for the purpose of exploring ADR. (Motions for Joinder of Parties and to Amended Pleadings due by 8/16/2019., Claim Construction Opening Briefs due by 3/15/2019., Claim Construction Answering Briefs due by 4/19/2019., A Markman Hearing (full day) is set for 5/20/2019 at 09:30 AM in Courtroom 4A., Fact Discovery completed by 11/15/2019., Opening Expert Reports due by 2/7/2020., Rebuttal Expert Reports due by 3/27/2020., Expert Discovery due by 5/22/2020., A Status Telephone Conference is set for 3/9/2020 at 10:00 AM to discuss the length of trial and consolidation., Proposed Final Pretrial Order due by 7/31/2020., A Final Pretrial Conference is set for 8/10/2020 at 10:00 AM in Courtroom 4A., A Bench Trial (Length TBD) is set for 9/14/2020 at 09:00 AM in Courtroom 4A. See Proposed Scheduling Order for more details). Ordered by Judge Gregory M. Sleet on 6/29/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Jun 28, 2018 | 48 | Proposed Order (8) Docket Text: PROPOSED ORDER -- Scheduling Order -- by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Attachments: # (1) Letter to The Honorable Gregory M. Sleet)(Blumenfeld, Jack) |
| Jun 28, 2018 | 48 | Letter to The Honorable Gregory M. Sleet (1) |
| Jun 27, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [46] STIPULATION TO EXTEND TIME to Answer Complaint to July 2, 2018 filed by Lek Pharmaceuticals d.d. Set/Reset Answer Deadlines: Lek Pharmaceuticals d.d. answer due 7/2/2018. Ordered by Judge Gregory M. Sleet on 6/27/2018. (mdb) |
| Jun 25, 2018 | 46 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Answer Complaint to July 2, 2018 - filed by Lek Pharmaceuticals d.d.. (Gattuso, Dominick) |
| Jun 25, 2018 | 47 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Paragraph 3 Disclosures of Defendant Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jun 18, 2018 | 44 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Zydus Worldwide and Cadila Healthcare's Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(O'Byrne, Stephanie) |
| Jun 18, 2018 | 45 | Notice of Service (11) Docket Text: NOTICE OF SERVICE of Plaintiffs' Paragraph 3 Initial Disclosures filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc..(Blumenfeld, Jack) |
| Jun 15, 2018 | 43 | Transcript (19) Docket Text: Official Transcript of Telephone Conference held on 06 14 18 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/6/2018. Redacted Transcript Deadline set for 7/16/2018. Release of Transcript Restriction set for 9/13/2018. (kjm) |
| Jun 14, 2018 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Scheduling Conference held on 6/14/2018. The court assigned the following deadlines: The Markman Hearing (full day) is set for 5/20/2019 at 9:30 AM in Courtroom 4A; a Telephone Conference, to discuss the length of trial and consolidation, is set for 3/9/2020 at 10:00 AM; the Final Proposed Pretrial Order is due by the close of business on 7/31/2020; the Final Pretrial Conference is set for 8/10/2020 at 10:00 AM in Courtroom 4A; and the Bench Trial (length TBD) is set for 9/14/2020 at 9:00 AM in Courtroom 4A. The cases are referred to the Magistrate Judge for exploring ADR. An amended proposed scheduling order is due by 6/28/2018. The parties shall work out the rest of the schedule, given the dates and orders provided. (Court Reporter Kevin Maurer.) Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) Modified on 6/14/2018 (mdb). |
| Jun 14, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Minute Entry dated today has been corrected to reflect that the Final Pretrial Conference is set for 8/10/2020 at 10:00 AM in Courtroom 4A. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Jun 6, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER re (31 in 1:18-cv-00237-GMS, 37 in 1:18-cv-00275-GMS, 26 in 1:18-cv-00192-GMS, 22 in 1:18-cv-00247-GMS) Joint Status Report - A Scheduling Telephone Conference is set for 6/14/2018 at 02:00 PM before Judge Gregory M. Sleet. The plaintiffs shall arrange the call and contact Chambers at (32) 573-4559 once all parties are on the line. Ordered by Judge Gregory M. Sleet on 6/6/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Jun 5, 2018 | 40 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial Disclosures of Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jun 5, 2018 | 41 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC and Cadila Healthcare Limited's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Cadila Healthcare Limited, Zydus Worldwide DMCC.(Moore, David) |
| Jun 5, 2018 | 42 | Notice of Service (12) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Pharmacyclics LLC and Janssen Biotech, Inc.'s Initial Disclosures Pursuant to Rule 26(a)(1) and (2) Plaintiffs Pharmacyclics LLC and Janssen Biotech, Inc.'s Identification of Accused Products and Asserted Patents filed by Pharmacyclics LLC, Janssen Biotech Inc..(Blumenfeld, Jack) |
| May 29, 2018 | 38 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, with Jury Demand by Sandoz Inc..(Gattuso, Dominick) |
| May 29, 2018 | 39 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Sandoz Inc. filed by Sandoz Inc.. (Gattuso, Dominick) |
| May 25, 2018 | 37 | Status Report (19) Docket Text: Joint STATUS REPORT by Janssen Biotech, Inc., Pharmacyclics LLC. (Attachments: # (1) Proposed Schedulng Order)(Blumenfeld, Jack) |
| May 25, 2018 | 37 | Proposed Schedulng Order (10) |
| May 24, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (35 in 1:18-cv-00275-GMS, 25 in 1:18-cv-00192-GMS, 29 in 1:18-cv-00237-GMS, 21 in 1:18-cv-00247-GMS) STIPULATION TO EXTEND TIME for the parties to submit the joint status report and proposed scheduling order to May 25, 2018 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 5/24/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| May 24, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [36] STIPULATION TO EXTEND TIME for Plaintiffs to move, answer, or otherwise respond to Teva's counterclaims to July 5, 2018 filed by Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 5/24/2018. (mdb) |
| May 23, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Carolina Veltri,Natalie C. Clayton,Siraj M. Abhyankar for Lek Pharmaceuticals d.d., Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| May 23, 2018 | 36 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Plaintiffs to move, answer, or otherwise respond to Teva's counterclaims to July 5, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC. (Blumenfeld, Jack) |
| May 22, 2018 | 35 | Stipulation to EXTEND Time (7) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit the joint status report and proposed scheduling order to May 25, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Noreika, Maryellen) |
| May 21, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [34] MOTION for Pro Hac Vice Appearance of Attorney Natalie C. Clayton, Siraj M. Abhyankar and Carolina Veltri filed by Lek Pharmaceuticals d.d., Sandoz Inc.. Ordered by Judge Gregory M. Sleet on 5/21/2018. (mdb) |
| May 18, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (28 in 1:18-cv-00237-GMS, 24 in 1:18-cv-00192-GMS, 33 in 1:18-cv-00275-GMS, 20 in 1:18-cv-00247-GMS) MOTION for Pro Hac Vice Appearance of Attorney Nicole A. Conlon filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 5/18/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| May 18, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [32] Stipulation filed by Lek Pharmaceuticals d.d., Set/Reset Answer Deadlines: Lek Pharmaceuticals d.d. answer due 6/25/2018.. Ordered by Judge Gregory M. Sleet on 5/18/2018. (mdb) |
| May 18, 2018 | 34 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Natalie C. Clayton, Siraj M. Abhyankar and Carolina Veltri - filed by Lek Pharmaceuticals d.d., Sandoz Inc.. (Gattuso, Dominick) |
| May 17, 2018 | 32 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order Regarding Service of Process on Defendant Lek Pharmaceuticals d.d. and Extension of Time for Defendant Lek Pharmaceutical d.d. to Respond to the Complaint by Lek Pharmaceuticals d.d.. (Gattuso, Dominick) |
| May 17, 2018 | 33 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Nicole A. Conlon - filed by Janssen Biotech, Inc. (Noreika, Maryellen) Modified on 5/17/2018 (ceg). |
| May 15, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (26 in 1:18-cv-00237-GMS, 18 in 1:18-cv-00247-GMS, 30 in 1:18-cv-00275-GMS, 23 in 1:18-cv-00192-GMS) STIPULATION TO EXTEND TIME for the parties to submit the Joint Status Report and proposed scheduling order to May 22, 2018 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 5/15/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| May 15, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [31] STIPULATION TO EXTEND TIME to Answer Complaint to May 29, 2018 filed by Sandoz Inc., Set/Reset Answer Deadlines: Sandoz Inc. answer due 5/29/2018.. Ordered by Judge Gregory M. Sleet on 5/15/2018. (mdb) |
| May 14, 2018 | 30 | Stipulation to EXTEND Time (6) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit the Joint Status Report and proposed scheduling order to May 22, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Blumenfeld, Jack) |
| May 14, 2018 | 31 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Answer Complaint to May 29, 2018 - filed by Sandoz Inc.. (Gattuso, Dominick) |
| May 10, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [29] STIPULATION TO EXTEND TIME for Plaintiffs to move, answer, or otherwise respond to Teva's counterclaims to June 4, 2018 filed by Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 5/10/2018. (mdb) |
| May 9, 2018 | 29 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Plaintiffs to move, answer, or otherwise respond to Teva's counterclaims to June 4, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC. (Blumenfeld, Jack) |
| Apr 23, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Disclosure Statement (formerly DI 28) has been removed from the docket per request from the filer. (mdb) |
| Apr 23, 2018 | 27 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Janssen Biotech, Inc., Pharmacyclics LLC by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Apr 23, 2018 | 28 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Apr 19, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Richard J. Berman, Gary A. Coad, Taniel E. Anderson, Jay R. Deshmukh, Bradford C. Frese, and Janine A. Carlan for Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Apr 18, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [26] MOTION for Pro Hac Vice Appearance of Attorney Jay R. Deshmukh, Richard J. Berman, Janine A. Carlan, Bradford C. Frese, Taniel E. Anderson and Gary A. Coad of Arent Fox LLP filed by Zydus Worldwide DMCC, Cadila Healthcare Limited. Ordered by Judge Gregory M. Sleet on 4/18/2018. (mdb) |
| Apr 16, 2018 | 26 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jay R. Deshmukh, Richard J. Berman, Janine A. Carlan, Bradford C. Frese, Taniel E. Anderson and Gary A. Coad of Arent Fox LLP - filed by Cadila Healthcare Limited, Zydus Worldwide DMCC. (Palapura, Bindu) |
| Apr 13, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (22 in 1:18-cv-00192-GMS, 25 in 1:18-cv-00275-GMS, 20 in 1:18-cv-00237-GMS, 13 in 1:18-cv-00247-GMS) STIPULATION TO EXTEND TIME to Submit Joint Status Report and Proposed Scheduling Order to May 15, 2018 filed by Janssen Biotech Inc., Janssen Biotech, Inc., Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 4/13/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Apr 12, 2018 | 25 | Stipulation to EXTEND Time (9) Docket Text: STIPULATION TO EXTEND TIME to Submit Joint Status Report and Proposed Scheduling Order to May 15, 2018 - filed by Janssen Biotech, Inc., Pharmacyclics LLC, Janssen Biotech Inc.. (Blumenfeld, Jack) |
| Apr 11, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (21 in 1:18-cv-00192-GMS, 24 in 1:18-cv-00275-GMS, 12 in 1:18-cv-00247-GMS) MOTION for Pro Hac Vice Appearance of Attorney Gregory L. Diskant, Irena Royzman, Jordan M. Engelhardt, and Lachlan Campbell-Verduyn filed by Janssen Biotech, Inc.. Ordered by Judge Gregory M. Sleet on 4/11/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Apr 11, 2018 | 24 | Motion for Leave to Appear Pro Hac Vice (10) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Gregory L. Diskant, Irena Royzman, Jordan M. Engelhardt, and Lachlan Campbell-Verduyn - filed by Janssen Biotech, Inc.. (Blumenfeld, Jack) |
| Apr 10, 2018 | 23 | SO ORDERED (6) Docket Text: SO ORDERED - re [22] Stipulation of Dismissal Dismissing Defendant Teva Pharmaceutical Industries Ltd. Without Prejudice And Amending Caption To Reflect Same. Party Teva Pharmaceutical Industries Ltd. terminated.. Signed by Judge Gregory M. Sleet on 4/10/2018. (mdb) |
| Apr 6, 2018 | 22 | Stipulation of Dismissal (6) Docket Text: STIPULATION of Dismissal Dismissing Defendant Teva Pharmaceutical Industries Ltd. Without Prejudice And Amending Caption To Reflect Same by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) Modified on 4/6/2018 (mdb). |
| Apr 5, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re (19 in 1:18-cv-00192-GMS, 11 in 1:18-cv-00247-GMS, 13 in 1:18-cv-00237-GMS, 20 in 1:18-cv-00275-GMS) MOTION for Pro Hac Vice Appearance of Attorney Christopher N. Sipes, Erica N. Andersen, Brianne Bharkhda, and Nicholas L. Evoy filed by Pharmacyclics LLC. Ordered by Judge Gregory M. Sleet on 4/5/2018. Associated Cases: 1:18-cv-00192-GMS, 1:18-cv-00237-GMS, 1:18-cv-00247-GMS, 1:18-cv-00275-GMS(mdb) |
| Apr 5, 2018 | 21 | Answer to Counterclaim (30) Docket Text: ANSWER to [15] Answer to Complaint, Counterclaim by Janssen Biotech, Inc., Pharmacyclics LLC.(Noreika, Maryellen) |
| Apr 3, 2018 | 20 | Motion for Leave to Appear Pro Hac Vice (11) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christopher N. Sipes, Erica N. Andersen, Brianne Bharkhda, and Nicholas L. Evoy - filed by Pharmacyclics LLC. (Blumenfeld, Jack) |
| Mar 23, 2018 | 18 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Sandoz Inc. on 3/22/2018 by Janssen Biotech, Inc., Pharmacyclics LLC. Waiver of Service due by 4/23/2018. (Noreika, Maryellen) |
| Mar 23, 2018 | 19 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Janssen Biotech, Inc., Pharmacyclics LLC: For Sandoz Inc. waiver sent on 3/22/2018, answer due 5/21/2018. (Noreika, Maryellen) |
| Mar 19, 2018 | 17 | Order (2) Docket Text: ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 3/19/2018. (asw) |
| Mar 15, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [14] MOTION for Pro Hac Vice Appearance of Attorney Helena Berezowskyj and Rhiannon I. D'Agostin filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. Ordered by Judge Gregory M. Sleet on 3/15/2018. (mdb) |
| Mar 15, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Rhiannon I. D'Agostin,Helena Berezowskyj for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm) |
| Mar 15, 2018 | 15 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Janssen Biotech, Inc., Pharmacyclics LLC by Zydus Worldwide DMCC, Cadila Healthcare Limited.(Moore, David) |
| Mar 15, 2018 | 16 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cadila Healthcare Limited for Zydus Worldwide DMCC; Corporate Parent none for Cadila Healthcare Limited filed by Cadila Healthcare Limited, Zydus Worldwide DMCC. (Moore, David) |
| Mar 14, 2018 | 14 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Helena Berezowskyj and Rhiannon I. D'Agostin - filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Mar 8, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED - re [13] MOTION for Pro Hac Vice Appearance of Attorney Gary E. Hood, Luke T. Shannon and Mark T. Deming filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. Ordered by Judge Gregory M. Sleet on 3/8/2018. (mdb) |
| Mar 8, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Gary E. Hood,Luke T. Shannon,Mark T. Deming for Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| Mar 6, 2018 | 13 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Gary E. Hood, Luke T. Shannon and Mark T. Deming - filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Feb 26, 2018 | 9 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Teva Pharmaceuticals USA, Inc. on 2/20/2018 by Janssen Biotech, Inc., Pharmacyclics LLC. Waiver of Service due by 3/22/2018. (Blumenfeld, Jack) |
| Feb 26, 2018 | 10 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Pharmacyclics LLC, Janssen Biotech, Inc.: For Teva Pharmaceuticals USA, Inc. waiver sent on 2/20/2018, answer due 4/23/2018. (Blumenfeld, Jack) |
| Feb 26, 2018 | 11 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Pharmacyclics LLC, Janssen Biotech, Inc.. Cadila Healthcare Limited served on 2/22/2018, answer due 3/15/2018. (Blumenfeld, Jack) |
| Feb 26, 2018 | 12 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Pharmacyclics LLC, Janssen Biotech, Inc.. Zydus Worldwide DMCC served on 2/22/2018, answer due 3/15/2018. (Blumenfeld, Jack) |
| Feb 21, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. (nms) |
| Feb 16, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Cadila Healthcare Limited on 2/16/2018; Lek Pharmaceuticals d.d. on 2/16/2018; Sandoz Inc. on 2/16/2018; Teva Pharmaceutical Industries Ltd. on 2/16/2018; Teva Pharmaceuticals USA, Inc. on 2/16/2018; Zydus Worldwide DMCC on 2/16/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (crb) |
| Feb 16, 2018 | 1 | Exhibit A - Q (1566) |
| Feb 16, 2018 | 1 | Exhibit R - T (206) |
| Feb 16, 2018 | 1 | Civil Cover Sheet (1) |
| Feb 16, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (crb) |
| Feb 16, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/4/18. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 5/13/2021. (crb) |
| Feb 16, 2018 | 4 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/5/18. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 5/13/2021. (crb) |
| Feb 16, 2018 | 5 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/4/18. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 5/13/2021. (crb) |
| Feb 16, 2018 | 6 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attachment. (crb) |
| Feb 16, 2018 | 7 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Pharmacyclics LLC filed by Pharmacyclics LLC. (crb) |
| Feb 16, 2018 | 8 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Biotech, Inc. filed by Janssen Biotech, Inc. (crb) |
| Feb 16, 2018 | 1 | Complaint* (1) |
